We are live on ! Find out more
NDRA icon

ENDRA Life Sciences
NDRA

13 hedge funds and large institutions have $1.54M invested in ENDRA Life Sciences in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% less ownership

Funds ownership: 0% → 0% (-0%)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

7% less funds holding

Funds holding: 14 → 13 (-1)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

50% less capital invested

Capital invested by funds: $3.06M → $1.54M (-$1.52M)

Holders
13
Holders Change
-1
Holders Change %
-7.14%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$71.7K
2
TSS
Two Sigma Securities
New York
+$35.9K
3
TRCT
Tower Research Capital (TRC)
New York
+$17.9K

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$251K
2
VF
Virtu Financial
New York
-$50K
3
RJA
Raymond James & Associates
Florida
-$49K
4
Citadel Advisors
Citadel Advisors
Florida
-$34K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$471K -$251K -14 -29%
Morgan Stanley
2
Morgan Stanley
New York
$332K – – –
NA
3
NewEdge Advisors
Louisiana
$258K – – –
Renaissance Technologies
4
Renaissance Technologies
New York
$136K +$71.7K +4 +67%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$126K – – –
State Street
6
State Street
Massachusetts
$41K – – –
BlackRock
7
BlackRock
New York
$40K – – –
5L
8
55I LLC
Massachusetts
$35K – – –
Northern Trust
9
Northern Trust
Illinois
$25K – – –
TSS
10
Two Sigma Securities
New York
$22K +$35.9K +2 New
Osaic Holdings
11
Osaic Holdings
Arizona
$17K – – –
UBS Group
12
UBS Group
Switzerland
$11K – – –
TRCT
13
Tower Research Capital (TRC)
New York
$8K +$17.9K +1 New
IC
14
IEQ Capital
California
$7K – – –
Royal Bank of Canada
15
Royal Bank of Canada
Ontario, Canada
$6K – – –
Skandinaviska Enskilda Banken (SEB)
16
Skandinaviska Enskilda Banken (SEB)
Sweden
$2K – – –
National Bank of Canada
17
National Bank of Canada
Quebec, Canada
$1K – – –
WAM
18
Worth Asset Management
Texas
$1K – – –
RJA
19
Raymond James & Associates
Florida
– -$49K -2 Closed
VF
20
Virtu Financial
New York
– -$50K -2 Closed
Citadel Advisors
21
Citadel Advisors
Florida
– -$34K -1 Closed

NDRA Hedge Fund Activity: Q1 2022 in Review

13 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in ENDRA Life Sciences (NDRA) for Q1 2022, worth a combined $1.54M — down 50% from $3.06M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of NDRA and 2 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.

The largest buyer was Renaissance Technologies, adding an estimated $71.7K. The largest seller was Vanguard Group, cutting an estimated $251K.

  • 13 institutional investors held ENDRA Life Sciences (NDRA) as of Q1 2022, down from 14 in Q4 2021.
  • Funds reported $1.54M of ENDRA Life Sciences stock for Q1 2022, down 50% quarter-over-quarter.
  • 2 funds opened new ENDRA Life Sciences positions in Q1 2022 and 3 closed out, a net change of -1 holder.
  • The largest ENDRA Life Sciences buyer in Q1 2022 was Renaissance Technologies, an estimated $71.7K added.
  • The largest ENDRA Life Sciences seller in Q1 2022 was Vanguard Group, an estimated $251K sold.

Based on aggregated 13F filings for Q1 2022.